PEDAL, NCT02386839 / 2014-003556-31: Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) |
|
|
| Completed | 2 | 76 | Europe, US | rhIGF-1/rhIGFBP-3, Mecasermin rinfabate | Shire | Retinopathy of Prematurity (ROP) | 09/21 | 09/21 | | |
NCT03253263 / 2018-001393-16: A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants |
|
|
| Recruiting | 2 | 338 | Europe, Canada, Japan, US | OHB-607, Mecasermin Rinfabate | OHB Neonatology Ltd. | Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP) | 01/26 | 01/28 | | |
NCT00233519: Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1) |
|
|
| Completed | 1/2 | 17 | US | SomatoKine/IPLEX | University of Rochester, National Institute of Neurological Disorders and Stroke (NINDS), Imsmed Incorporated | Myotonic Dystrophy | 05/08 | 05/08 | | |
